Yue Gao, Shicheng Fan, Xuan Li, Pengfei Zhao, Yanying Zhou, Jianing Tian et al. PXR activation mitigates hepatic fibrosis by suppressing β-catenin/TCF4–LECT2 axis-mediated angiogenesis. // Acta Pharmaceutica Sinica B. – 2026. – DOI: 10.1016/j.apsb.2026.11.029. – URL: https://doi.org/10.1016/j.apsb.2026.11.029
Yue Gao, Shicheng Fan, Xuan Li, Pengfei Zhao, Yanying Zhou, Jianing Tian, Jianhong Fang, Xiao Yang, Weijie Zhou, Zhenwei Peng, Min Huang, & Huichang Bi (2026). PXR activation mitigates hepatic fibrosis by suppressing β-catenin/TCF4–LECT2 axis-mediated angiogenesis. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.11.029
Yue Gao, et al. “PXR activation mitigates hepatic fibrosis by suppressing β-catenin/TCF4–LECT2 axis-mediated angiogenesis.” Acta Pharmaceutica Sinica B, 2026. doi:10.1016/j.apsb.2026.11.029.
@article{Gao2026,
title = {PXR activation mitigates hepatic fibrosis by suppressing β-catenin/TCF4–LECT2 axis-mediated angiogenesis},
author = {Gao, Yue and Fan, Shicheng and Li, Xuan and Zhao, Pengfei and Zhou, Yanying and Tian, Jianing and Fang, Jianhong and Yang, Xiao and Zhou, Weijie and Peng, Zhenwei and Huang, Min and Bi, Huichang},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
doi = {10.1016/j.apsb.2026.11.029},
url = {https://doi.org/10.1016/j.apsb.2026.11.029}
}